Cargando…
N of 1 case reports of exceptional responders accrued from pancreatic cancer patients enrolled in first-in-man studies from 2002 through 2012
PURPOSE: To identify exceptional responders among patients with advanced pancreatic cancer enrolled in first-in-man (FIM) studies. METHODS: A Scopus search identified 66 FIM studies that enrolled at least one patient with advanced pancreatic cancer between 2002-2012. Descriptive statistics were used...
Autores principales: | Garrido-Laguna, Ignacio, Tometich, Danielle, Hu, Nan, Ying, Jian, Geiersbach, Katherine, Whisenant, Jonathan, Wang, Kai, Ross, Jeffrey S., Sharma, Sunil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394134/ https://www.ncbi.nlm.nih.gov/pubmed/25897431 |
Ejemplares similares
-
Interpretation of Results from Under‐accruing Studies
por: Kravets, Sasha, et al.
Publicado: (2018) -
Barriers to accrue to clinical trials and possible solutions
por: Winters, Z E, et al.
Publicado: (2014) -
Application of deep learning in recognition of accrued earnings management
por: Li, Jia, et al.
Publicado: (2023) -
One-third of patients with lupus nephritis classified as complete responders continue to accrue progressive renal damage despite resolution of proteinuria
por: Weeding, Emma, et al.
Publicado: (2022) -
Visualizing the quality of partially accruing data for use in
decision making
por: Eaton, Julia, et al.
Publicado: (2015)